| Literature DB >> 35794550 |
Sinead A Keogh1, Jessica H Leibler1, Caryn M Sennett Decker1, Juan Jose Amador Velázquez1,2, Emmanuel R Jarquin3, Damaris Lopez-Pilarte1,2, Ramon Garcia-Trabanino3,4,5, Iris S Delgado1,2, Zoe E Petropoulos1, David J Friedman6, Magaly Rosario Amador Sánchez1,2, Raul Guevara3, Michael D McClean1, Daniel R Brooks2, Madeleine K Scammell7.
Abstract
BACKGROUND: Mortality from chronic kidney disease of unknown etiology (CKDu) is extremely high along the Pacific coast of Central America, particularly among sugarcane workers. The Mesoamerican Nephropathy Occupational Study (MANOS) is a prospective cohort study of CKDu among agricultural and non-agricultural workers in El Salvador and Nicaragua. The objective of this manuscript is to describe the MANOS cohort recruitment, baseline data collection, and CKDu prevalence after two rounds.Entities:
Keywords: CKD; CKD-EPI; Chronic kidney disease of unknown etiology; Cohort study; KDIGO; Kidney function; Mesoamerican nephropathy; Occupational epidemiology; Prevalence; Workers
Mesh:
Year: 2022 PMID: 35794550 PMCID: PMC9261054 DOI: 10.1186/s12882-022-02861-0
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.585
Fig. 1Infographics of MANOS Round 1 data collection process which were shared with workers.
Fig. 2Round 1 data collection process at the work site.
Fig. 3Cohort derivation.
MANOS Cohort at Round 1
| MANOS Cohort | 569 (100) |
| El Salvador | 279 (49.0) |
| Nicaragua | 290 (51.0) |
| 18–24 | 172 (30.2) |
| 25–34 | 250 (43.9) |
| 35–45 | 147 (25.8) |
| No formal schooling | 60 (10.5) |
| Primary | 275 (48.3) |
| Secondary | 219 (38.5) |
| University | 15 (2.6) |
| > 10 | 374 (65.7) |
| 6 to 10 | 83 (14.6) |
| 2 to 5 | 81 (14.2) |
| < 2 | 30 (5.3) |
| Missing | 1 (0.2) |
| Sugarcane | 235 (41.3) |
| Brick | 107 (18.8) |
| Corn | 110 (19.3) |
| Plantain | 59 (10.4) |
| Road construction | 58 (10.2) |
Primary job tasks in person-days over three days of monitoring at baseline by country, industry and company
| El Salvador | Nicaragua | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| SUGAR1 | SUGAR2 | CORN | CONS | SUGAR1 | SUGAR2 | SUGAR3 | PLANT | BRICK | |
| 55 | 56 | 110 | 58 | 22 | 52 | 50 | 59 | 107 | |
| 165 (100) | 168 (100) | 330 (100) | 174 (100) | 66 (100) | 156 (100) | 150 (100) | 177 (100) | 321 (100) | |
| 89 (54) | 82 (49) | 254 (77) | – | – | 94 (60) | 90 (60) | – | – | |
| – | 13 (8) | 59 (18) | – | 66 (100) | 62 (40) | 60 (40) | 39 (22) | – | |
| 17 (10) | 8 (5) | – | – | – | – | – | 25 (14) | – | |
| – | 54 (32) | – | – | – | – | – | – | – | |
| 8 (5) | – | – | – | – | – | – | 57 (32) | – | |
| 35 (21) | – | – | 12 (7) | – | – | – | – | – | |
| – | – | – | 111 (64) | – | – | – | – | – | |
| – | – | – | 14 (8) | – | – | – | – | – | |
| – | – | – | 14 (8) | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 228 (71) | |
| – | – | – | – | – | – | – | – | 83 (26) | |
| 17 (10) | 11 (6) | 17 (5) | 23 (13) | – | – | – | 56 (32) | 7 (3) | |
Participants with CKD Stages 3–5 at Baseline
| CKD Stage (eGFR mL/min/1.73 m | n (%) |
|---|---|
Overall CKD Prevalence, Stages 3–5 combined (< 60) | 42 (7.4) |
| Stage 3a (45 to < 60) | 9 (1.6) |
| Stage 3b (30 to < 45) | 16 (2.8) |
| Stage 4 (15 to < 30) | 9 (1.6) |
| Stage 5 (< 15) | 7 (1.2) |
CKD Cases, and Crude and Age-Standardized CKD Prevalence among MANOS participants by demographic variables
| Demographic | CKD cases | Crude Prevalencea % | Age-standardized Prevalencea |
|---|---|---|---|
| 18–24 ( | 1 (2.4) | 0.6 | – |
| 25–34 ( | 14 (33.3) | 5.6 | – |
| 35–45 ( | 27 (64.3) | 18.4 | – |
| El Salvador ( | 28 (66.6) | 10.0 | 10.1 (6.7, 13.5) |
| Nicaragua ( | 14 (33.3) | 4.8 | 4.6 (2.3, 7.0) |
| No father or brother with CKD ( | 29 (69.0) | 6.3 | 6.9 (4.5, 9.2) |
| Brother with CKD ( | 6 (14.3) | 12.8 | 9.1 (2.3, 15.8) |
| Father with CKD ( | 10 (23.8) | 11.9 | 9.4 (4.0, 14.9) |
| Father OR brother with CKD ( | 13 (31.0) | 11.6 | 9.0 (4.4, 13.6) |
| Father AND brother with CKD ( | 3 (7.1) | 15.8 | 10.8 (0.0, 22.1) |
| Father Unknown CKD status ( | 3 (7.1) | 7.1 | 9.2 (0.0, 18.5) |
| El Salvador Sugarcane ( | 16 (38.1) | 14.4 | 14.1 (7.9, 20.3) |
| Nicaragua Sugarcane ( | 1 (2.4) | 0.8 | 0.6 (0.0, 1.8) |
| Brick ( | 10 (23.8) | 9.4 | 8.1 (3.3, 12.8) |
| Corn ( | 10 (23.8) | 9.1 | 11.6 (5.6, 17.6) |
| Plantain ( | 3 (7.2) | 5.1 | 4.9 (0.0, 10.2) |
| Road construction ( | 2 (4.8) | 3.4 | 2.9 (0.0, 6.7) |
a Denominator for prevalence appears in the first column of the corresponding row
Estimated GFR among all MANOS participants and by CKD status at baseline with age-adjusted comparisons of serum kidney function parameters between groups at Round 1
| Parameter | Reference range | All MANOS Mean ± SD | CKD+ | CKD- | Age-Adjusted |
|---|---|---|---|---|---|
| eGFR (ml/min/1.73min2) | > 90 | 106.7 ± 28.2 | 33.6 ± 15.5 | 112.7 ± 19.1 | −68.6 (− 74.1, − 63.1) |
| Creatinine (mg/dL) | 0.60–1.35 | 1.06 ± 0.81 | 3.10 ± 1.96 | 0.89 ± 0.21 | 2.07 (1.90, 2.26) |
| Albumin (g/dL) | 3.6–5.1 | 4.5 ± 0.26 | 4.4 ± 0.26 | 4.5 ± 0.26 | 0.03 (− 0.08, 0.13) |
| Calcium (mg/dL) | 8.6–10.3 | 9.3 ± 0.38 | 9.1 ± 0.52 | 9.3 ± 0.36 | − 0.17 (− 0.28, − 0.05) |
| Carbon dioxide (mmol/L) | 20–32 | 26.2 ± 3.0 | 25.4 ± 3.7 | 26.3 ± 3.0 | − 0.96 (− 0.91, 1.00) |
| Chloride (mmol/L) | 98–110 | 100.7 ± 3.2 | 99.3 ± 5.2 | 100.8 ± 3.0 | 0.99 (0.98, 1.00) |
| Creatine phosphokinase (U/L) | 39–308 | 241.8 ± 142.0 | 298.5 ± 162.4 | 239.1 ± 140.8 | 1.16 (0.92, 1.45) |
| Glucose (mg/dL) | 65–99 | 90.3 ± 16.0 | 96.17 ± 17.1 | 89.8 ± 15.8 | 3.61 (− 1.28, 8.50) |
| Blood urea nitrogen (BUN) (mg/dL) | 7–25 | 12.3 ± 6.4 | 25.9 ± 9.7 | 10.8 ± 3.6 | 14.7 (12.8, 16.6) |
| Phosphorous (mg/dL) | 2.5–4.5 | 3.6 ± 0.67 | 3.7 ± 0.92 | 3.6 ± 0.65 | 0.26 (0.06, 0.46) |
| Potassium (mmol/L) | 3.5–5.3 | 3.9 ± 0.44 | 3.7 ± 0.66 | 4.0 ± 0.43 | −0.19 (− 0.33, − 0.54) |
| Sodium (mmol/L) | 135–146 | 138.0 ± 2.4 | 136.3 ± 3.5 | 138.1 ± 2.2 | − 1.54 (− 2.26, − 0.82) |
| Uric acid (mg/dL) | 2.5–8.0 | 5.8 ± 1.7 | 9.1 ± 2.2 | 5.6 ± 1.3 | 3.13 (2.70, 3.55) |
Reference ranges are from Quest Diagnostics, with the exception of urea and total creatinine phosphokinase (CPK), which are from the Nicaraguan National Laboratory. Reference ranges are for men ages 20–49 years. The serum creatinine reference range for men ages 18–19 is 0.60–1.26 (mg/dL) and for serum calcium is 8.9–10.4 (mg/dL)
Age-adjusted mean difference by CKD status was calculated using linear regression
All values presented were collected prior to the work shift on Day 1 of baseline enrollment
Albumin and carbon dioxide were only assessed in samples from El Salvador (n = 279)
Log transformed for linear regression. Exponentiated beta coefficients and 95% CIs are displayed
Total creatinine phosphokinase was only assessed in samples from Nicaragua (n = 290)